Side-by-side comparison of AI visibility scores, market position, and capabilities
GM-backed autonomous vehicle company paused robotaxi operations in 2023 after a safety incident; rebuilding under new leadership in 2025 with $10B+ cumulative investment from GM, Honda, Microsoft, and institutional investors.
Cruise is an autonomous vehicle company developing and operating self-driving cars, primarily focused on robotaxi services in urban environments. Founded in 2013 and headquartered in San Francisco, Cruise was acquired by General Motors in 2016 for approximately $1 billion and has since received over $10 billion in cumulative investment from GM, Honda, Microsoft, and institutional investors. The company spent years developing its AV technology on the streets of San Francisco, operating driverless commercial robotaxi service in 2022-2023.
Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.
Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.